BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34432915)

  • 1. Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma.
    Wang L; Wang X; Jia Y; Guo F; Zhengjun S; Shao Z
    Mol Carcinog; 2021 Nov; 60(11):758-768. PubMed ID: 34432915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
    Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
    Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma.
    Hao JJ; Lin DC; Dinh HQ; Mayakonda A; Jiang YY; Chang C; Jiang Y; Lu CC; Shi ZZ; Xu X; Zhang Y; Cai Y; Wang JW; Zhan QM; Wei WQ; Berman BP; Wang MR; Koeffler HP
    Nat Genet; 2016 Dec; 48(12):1500-1507. PubMed ID: 27749841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
    Xie S; Cai ZG; Shan XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
    Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
    J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma.
    Gabusi A; Gissi DB; Montebugnoli L; Asioli S; Tarsitano A; Marchetti C; Balbi T; Helliwell TR; Foschini MP; Morandi L
    Virchows Arch; 2020 Apr; 476(4):585-595. PubMed ID: 31468114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
    Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
    Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma.
    Lv L; Wang Q; Yang Y; Ji H
    Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
    Bruckman KC; Schönleben F; Qiu W; Woo VL; Su GH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):632-7. PubMed ID: 20813562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencing.
    Tabatabaeifar S; Thomassen M; Larsen MJ; Larsen SR; Kruse TA; Sørensen JA
    Oncotarget; 2017 Mar; 8(10):16571-16580. PubMed ID: 28157713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.
    Sequeira I; Rashid M; Tomás IM; Williams MJ; Graham TA; Adams DJ; Vigilante A; Watt FM
    Nat Commun; 2020 Nov; 11(1):5671. PubMed ID: 33168804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
    Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
    J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.